Literature DB >> 6769518

Factor VIII-related protein circulates in normal human plasma as high molecular weight multimers.

L W Hoyer, J R Shainoff.   

Abstract

The size of human factor VIII-related protein in plasma has been determined by sodium dodecyl sulfate (SDS) glyoxyl agarose electrophoresis. The protein was immobilized after the electrophoresis by coupling it to the modified agarose, and it was identified by autoradiography using purified rabbit anti-factor VIII-related antigen (VIIR:Ag). A series of multimeric forms was identified with Mr of 0.85-12 x 10(6). The distribution of VIIR:Ag multimers was the same in heparin and citrate anticoagulated plasmas and in serum, and the pattern was the same after freezing as in plasma kept at 37 degrees C from the time of venipuncture until the electrophoresis was complete. These observations indicate that VIIR:Ag circulates in normal plasma as a population of very large multimers and that the size distribution is not an artifact induced by purification methods, freezing, or calcium chelation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6769518

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

1.  Effect of transmembrane pressure on Factor VIII yield in ATF perfusion culture for the production of recombinant human Factor VIII co-expressed with von Willebrand factor.

Authors:  Seung-Chul Kim; Sora An; Hyun-Ki Kim; Beom-Soo Park; Kyu-Heum Na; Byung-Gee Kim
Journal:  Cytotechnology       Date:  2015-10-13       Impact factor: 2.058

2.  Small bowel angiodysplasia associated with von Willebrand's disease: report of a case.

Authors:  Rosalia Patti; Piero L Almasio; Salvatore Buscemi; Claudio Tripodo; Gaetano Di Vita
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

3.  In-process controls and characterization of recombinate antihemophilic factor (recombinant).

Authors:  M Griffith; H Kingdon; S L Liu; W Burkart
Journal:  Ann Hematol       Date:  1991-09       Impact factor: 3.673

4.  Mediation of fibrin-induced release of von Willebrand factor from cultured endothelial cells by the fibrin beta chain.

Authors:  J A Ribes; F Ni; D D Wagner; C W Francis
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

5.  Mechanisms by which von Willebrand disease mutations destabilize the A2 domain.

Authors:  Amy J Xu; Timothy A Springer
Journal:  J Biol Chem       Date:  2013-01-15       Impact factor: 5.157

6.  Retinal cotton-wool spots: an early finding in diabetic retinopathy?

Authors:  M S Roy; M E Rick; K E Higgins; J C McCulloch
Journal:  Br J Ophthalmol       Date:  1986-10       Impact factor: 4.638

7.  Rapid formation of large molecular weight alpha-polymers in cross-linked fibrin induced by high factor XIII concentrations. Role of platelet factor XIII.

Authors:  C W Francis; V J Marder
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

8.  Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutations.

Authors:  Jeffrey J Sutherland; Lee A O'Brien; David Lillicrap; Donald F Weaver
Journal:  J Mol Model       Date:  2004-08-03       Impact factor: 1.810

9.  Von Willebrand's disease in two families of Doberman Pinschers.

Authors:  I B Johnstone; S Crane
Journal:  Can Vet J       Date:  1981-08       Impact factor: 1.008

10.  The pro-polypeptide of von Willebrand factor is required for the formation of a functional factor VIII-binding site on mature von Willebrand factor.

Authors:  A Leyte; J Voorberg; H B Van Schijndel; B Duim; H Pannekoek; J A Van Mourik
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.